About ym

YM BioSciences Inc. is a drug development company primarily focused on advancing CYT387, an orally administered inhibitor of both the JAK1 and JAK2 kinases, which have been implicated in a number of hematological and immune cell disorders including myeloproliferative neoplasms and inflammatory diseases as well as certain cancers. Positive interim results – more... 

Reviews

Overall

3.3
Based on 15 reviews
5 stars
4 stars
3 stars
2 stars
1 star
Work/Life Balance
3.2
Salary/Benefits
2.4
Job Security/Advancement
3.0
Management
3.5
Culture
3.1
Claim this company page
Headquarters
Mississauga Ontario, Canada
Revenue
$1.1 Million
Employees
11 to 50
Links
ym website